Agios Pharmaceuticals (AGIO) Earnings Analysis
Agios Pharmaceuticals (AGIO) next reports earnings on 2026-07-30, consensus EPS -1.65877 USD. Last quarter (2026-04-29) it beat with EPS -1.69 USD vs -1.81 USD est (+6.6%). It has beaten estimates in 4/8 recent quarters (50%). Trailing P/E -4.97.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does AGIO next report earnings?
| Next earnings date | 2026-07-30 |
|---|---|
| Consensus EPS estimate | -1.65877 USD |
| Revenue estimate | 0.03B |
AGIO earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-29 | -1.69 USD | -1.81 USD | +6.6% | Beat |
| 2026-02-12 | -1.85 USD | -1.97 USD | +6.1% | Beat |
| 2025-10-30 | -1.78 USD | -1.93 USD | +7.8% | Beat |
| 2025-07-31 | -1.93 USD | -1.74 USD | -10.9% | Miss |
| 2025-05-01 | -1.55 USD | -1.8 USD | +13.9% | Beat |
| 2025-02-13 | -1.74 USD | -1.69 USD | -3% | Miss |
| 2024-10-31 | 4.2 USD | 16.69 USD | -74.8% | Miss |
| 2024-08-01 | -1.69 USD | -1.58 USD | -7% | Miss |
Beat rate: 4/8 (50%) over reported quarters with consensus data.
AGIO valuation and analyst view
| Trailing P/E | -4.97 |
|---|---|
| Trailing EPS | -7.1893 USD |
| Price / book | 1.91 |
| Dividend yield | 0.00% |
| Market cap | 2.16B |
| Analyst consensus | Buy (22 buy / 7 hold / 0 sell) |
| Avg price target | 43 USD |
Related research pages
Frequently asked questions
When is Agios Pharmaceuticals (AGIO)'s next earnings date?
Agios Pharmaceuticals is next scheduled to report on 2026-07-30, with a consensus EPS estimate of -1.65877 USD and revenue estimate of 0.03B.
Did AGIO beat earnings last quarter?
In its 2026-04-29 report, AGIO posted EPS of -1.69 USD versus a -1.81 USD estimate — a beat of 6.6%.
What is AGIO's earnings track record?
Over the last 8 reported quarters with consensus data, AGIO beat estimates 4 times (50%).
What is AGIO's current P/E ratio and EPS?
AGIO trades at a trailing P/E of -4.97 on trailing EPS of -7.189297189265036 USD.
What do analysts rate AGIO?
Analyst consensus is "Buy" across 29 ratings (0 strong buy, 22 buy, 7 hold, 0 sell, 0 strong sell). Average 12-month price target: 43 USD.